Evidence map›Paper›PMID 26309039›Full record

ArticlePloS one2015

LytB1 and LytB2 of Mycobacterium tuberculosis Are Not Genetically Redundant.

Amanda Claire Brown, Rachel Kokoczka, Tanya Parish

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Amanda Claire BrownQueen Mary University of London, London, E1 2AD, United Kingdom; Barts & the London School of Medicine and Dentistry, London, E1 2AD, United Kingdom.
Rachel KokoczkaTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, 98102, United States of America.
Tanya ParishQueen Mary University of London, London, E1 2AD, United Kingdom; Barts & the London School of Medicine and Dentistry, London, E1 2AD, United Kingdom; TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, 98102, United States of America.
Queen Mary University of London · GBInfectious Disease Research Institute · US

Funding

Biotechnology and Biological Sciences Research Council BB/D000181/1NIAID NIH HHS R01AI0976550
6 · The paper itself

Abstract

Mycobacterium tuberculosis synthesises isoprenoid precursors via the MEP/DOXP pathway and at least five enzymes in the pathway (Dxs1, Dxr/IspC, IspD, IspF, and GcpE/IspG) are required for growth in vitro. We investigated the role of LytB (IspH) in M. tuberculosis; M. tuberculosis is unusual in that it has two homologs-LytB1 and LytB2. We were unable to delete the lytB2 gene unless we provided an additional copy elsewhere, demonstrating that this is the essential homolog. We expressed lytB1 from the lytB2 promoter and confirmed that this could not complement for loss of function of lytB2, despite LytB1 possessing all the previously described conserved critical residues. Interestingly the sole LytB homolog of Mycobacterium smegmatis was able to compensate for loss of LytB2 in M. tuberculosis. We tested translational fusions of LytB1 and LytB2 for functionality in M. tuberculosis, but only a fusion with 90% N-terminal LytB2 and 10% C-terminal LytB1 was functional. In order to identify the key difference between the two proteins, site directed mutagenesis was used to change LytB2 residues into their counterparts in LytB1. None of these amino acid substitutions was essential for function and all lytB2 mutant alleles were functional. In contrast, mutation of the key residues for [Fe4S4] cluster formation, as well as a catalytic residue in LytB1 did not result in functional complementation. Thus, although LytB1 and LytB2 are not genetically redundant, this is not dependent on small amino acid changes, but is likely to be a result of major overall structural differences.

Indexed as

Genes, EssentialAmino Acid SequenceBacterial ProteinsGenetic Complementation TestMolecular Sequence DataMutagenesis, Site-DirectedMycobacterium smegmatisMycobacterium tuberculosisOxidoreductasesPromoter Regions, GeneticProtein IsoformsBacterial ProteinsOxidoreductasesProtein Isoforms

Identifiers

PMID26309039
PMCPMC4550268
OpenAlexW1782808675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.